Treatment failure of nelfinavir-containing triple therapy can largely be explained by low nelfinavir plasma concentrations

DM Burger, PWH Hugen, RE Aarnoutse, RMW Hoetelmans, M Jambroes, PT Nieuwkerk, G Schreij, MME Schneider, Marchina Ende, JMA Lange, ICJ (Inge) Gyssens, S (Siem) de Marie

Research output: Contribution to journalArticleAcademicpeer-review

67 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)73-80
Number of pages8
JournalTherapeutic Drug Monitoring
Volume25
DOIs
Publication statusPublished - 2003

Research programs

  • EMC MM-04-28-04

Cite this